Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy

计划入组 225 人 · 首次发布于 2016 年 9 月 8 日

Evaluation of PDE MAX

计划入组 11 人 · 首次发布于 2020 年 12 月 17 日

PDE Inhibitors in DMD Study (Acute Dosing Study)

计划入组 12 人 · 首次发布于 2012 年 4 月 19 日

PDE-551

PDE 4 inhibitors (CJ)

PDE 7 inhibitors (inflammation)

PDS Biotechnology

United States

PE PHARMA PTE. LTD.

Singapore

ENDOFOTONICS PTE. LTD.

Singapore

Karma Biosciences Files Patents for Rapid-Acting Nasal PDE-5 Inhibitors with 5-Minute Onset

Nerandomilast: A Novel PDE4B Inhibitor Shows Promise in Treating Idiopathic Pulmonary Fibrosis

Pattern Computer Secures Global Patent Protection for AI-Discovered Triple-Negative Breast Cancer Therapy PCI020302